» Articles » PMID: 32299587

Transvalvular Flow Rate Determines Prognostic Value of Aortic Valve Area in Aortic Stenosis

Overview
Date 2020 Apr 18
PMID 32299587
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aortic valve area (AVA) ≤1.0 cm is a defining characteristic of severe aortic stenosis (AS). AVA can be underestimated at low transvalvular flow rate. Yet, the impact of flow rate on prognostic value of AVA ≤1.0 cm is unknown and is not incorporated into AS assessment.

Objectives: This study aimed to evaluate the effect of flow rate on prognostic value of AVA in AS.

Methods: In total, 1,131 patients with moderate or severe AS and complete clinical follow-up were included as part of a longitudinal database. The effect of flow rate (ratio of stroke volume to ejection time) on prognostic value of AVA ≤1.0 cm for time to death was evaluated, adjusting for confounders. Sensitivity analysis was performed to identify the optimal cutoff for prognostic threshold of AVA. The findings were validated in a separate external longitudinal cohort of 939 patients.

Results: Flow rate had a significant effect on prognostic value of AVA. AVA ≤1.0 cm was not prognostic for mortality (p = 0.15) if AVA was measured at flow rates below median (≤242 ml/s). In contrast, AVA ≤1.0 cm was highly prognostic for mortality (p = 0.003) if AVA was measured at flow rates above median (>242 ml/s). Findings were irrespective of multivariable adjustment for age, sex, and surgical/transcatheter aortic valve replacement (as time-dependent covariates); comorbidities; medications; and echocardiographic features. AVA ≤1.0 cm was also not an independent predictor of mortality below median flow rate in the validation cohort. The optimal flow rate cutoff for prognostic threshold was 210 ml/s.

Conclusions: Transvalvular flow rate determines prognostic value of AVA in AS. AVA measured at low flow rate is not a good prognostic marker and therefore not a good diagnostic marker for truly severe AS. Flow rate assessment should be incorporated into clinical diagnosis, classification, and prognosis of AS.

Citing Articles

Diagnostic Challenges in the Management of Aortic Valve Stenosis and the Role of Imaging: A Narrative Review.

Karelas D, Tatsis E, Oikonomidis D, Papadopoulos C J Clin Med. 2025; 14(4).

PMID: 40004761 PMC: 11856245. DOI: 10.3390/jcm14041231.


Machine learning cluster analysis identifies increased 12-month mortality risk in transcatheter aortic valve replacement recipients.

Meredith T, Mohammed F, Pomeroy A, Barbieri S, Meijering E, Jorm L Front Cardiovasc Med. 2025; 12:1444658.

PMID: 39974597 PMC: 11836646. DOI: 10.3389/fcvm.2025.1444658.


Impact of Stress Echocardiography on Aortic Valve Stenosis Management.

Synetos A, Vlasopoulou K, Drakopoulou M, Apostolos A, Ktenopoulos N, Katsaros O J Clin Med. 2024; 13(12).

PMID: 38930024 PMC: 11204470. DOI: 10.3390/jcm13123495.


The Flow Rate in Patients With Low-Gradient Aortic Stenosis.

Leitman M, Daoud M, Tyomkin V, Fuchs S Cureus. 2024; 16(5):e60776.

PMID: 38903309 PMC: 11188971. DOI: 10.7759/cureus.60776.


Combined Value of Dimensionless Index and Transvalvular Flow Rate in Risk Stratification of Aortic Stenosis.

Namasivayam M, Churchill T, Capoulade R, Pibarot P, Danik J, Picard M Am J Cardiol. 2023; 213:69-71.

PMID: 38103765 PMC: 10842843. DOI: 10.1016/j.amjcard.2023.12.008.


References
1.
Namasivayam M, Mceniery C, Wilkinson I, Yasmin , Cockroft J, McDonnell B . Different Effects of Vascular Aging on Ischemic Predisposition in Healthy Men and Women. Hypertension. 2018; 72(6):1294-1300. DOI: 10.1161/HYPERTENSIONAHA.118.11642. View

2.
Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

3.
Saeed S, Senior R, Chahal N, Lonnebakken M, Chambers J, Bahlmann E . Lower Transaortic Flow Rate Is Associated With Increased Mortality in Aortic Valve Stenosis. JACC Cardiovasc Imaging. 2017; 10(8):912-920. DOI: 10.1016/j.jcmg.2017.05.008. View

4.
Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

5.
Lindquist V, Spangler R, BLOUNT Jr S . A comparison between the effects of dynamic and isometric exercise as evaluated by the systolic time intervals in normal man. Am Heart J. 1973; 85(2):227-36. DOI: 10.1016/0002-8703(73)90464-x. View